105 related articles for article (PubMed ID: 22209498)
1. Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.
Verhaart IE; van Duijn RJ; den Adel B; Roest AA; Verschuuren JJ; Aartsma-Rus A; van der Weerd L
Neuromuscul Disord; 2012 May; 22(5):418-26. PubMed ID: 22209498
[TBL] [Abstract][Full Text] [Related]
2. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
3. Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.
Chun JL; O'Brien R; Berry SE
Neuromuscul Disord; 2012 Apr; 22(4):368-79. PubMed ID: 22266080
[TBL] [Abstract][Full Text] [Related]
4. Low dystrophin levels in heart can delay heart failure in mdx mice.
van Putten M; van der Pijl EM; Hulsker M; Verhaart IE; Nadarajah VD; van der Weerd L; Aartsma-Rus A
J Mol Cell Cardiol; 2014 Apr; 69():17-23. PubMed ID: 24486194
[TBL] [Abstract][Full Text] [Related]
5. Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.
Gaedigk R; Law DJ; Fitzgerald-Gustafson KM; McNulty SG; Nsumu NN; Modrcin AC; Rinaldi RJ; Pinson D; Fowler SC; Bilgen M; Burns J; Hauschka SD; White RA
Neuromuscul Disord; 2006 Mar; 16(3):192-203. PubMed ID: 16487708
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of dystrophinopathy in old mdx mice.
Lefaucheur JP; Pastoret C; Sebille A
Anat Rec; 1995 May; 242(1):70-6. PubMed ID: 7604983
[TBL] [Abstract][Full Text] [Related]
7. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
[TBL] [Abstract][Full Text] [Related]
8. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse.
Briguet A; Courdier-Fruh I; Foster M; Meier T; Magyar JP
Neuromuscul Disord; 2004 Oct; 14(10):675-82. PubMed ID: 15351425
[TBL] [Abstract][Full Text] [Related]
9. Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
Connolly AM; Keeling RM; Mehta S; Pestronk A; Sanes JR
Neuromuscul Disord; 2001 Nov; 11(8):703-12. PubMed ID: 11595512
[TBL] [Abstract][Full Text] [Related]
10. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
11. Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle.
Spencer MJ; Montecino-Rodriguez E; Dorshkind K; Tidball JG
Clin Immunol; 2001 Feb; 98(2):235-43. PubMed ID: 11161980
[TBL] [Abstract][Full Text] [Related]
12. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
13. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
14. Effect of propylthiouracil-induced hypothyroidism on the onset of skeletal muscle necrosis in dystrophin-deficient mdx mice.
McArdle A; Helliwell TR; Beckett GJ; Catapano M; Davis A; Jackson MJ
Clin Sci (Lond); 1998 Jul; 95(1):83-9. PubMed ID: 9662489
[TBL] [Abstract][Full Text] [Related]
15. Muscle genome-wide expression profiling during disease evolution in mdx mice.
Marotta M; Ruiz-Roig C; Sarria Y; Peiro JL; Nuñez F; Ceron J; Munell F; Roig-Quilis M
Physiol Genomics; 2009 Apr; 37(2):119-32. PubMed ID: 19223608
[TBL] [Abstract][Full Text] [Related]
16. Albumin targeting of damaged muscle fibres in the mdx mouse can be monitored by MRI.
Amthor H; Egelhof T; McKinnell I; Ladd ME; Janssen I; Weber J; Sinn H; Schrenk HH; Forsting M; Voit T; Straub V
Neuromuscul Disord; 2004 Dec; 14(12):791-6. PubMed ID: 15564034
[TBL] [Abstract][Full Text] [Related]
17. The absence of dystrophin rather than muscle degeneration causes acetylcholine receptor cluster defects in dystrophic muscle.
Kong J; Yang L; Li Q; Cao J; Yang J; Chen F; Wang Y; Zhang C
Neuroreport; 2012 Jan; 23(2):82-7. PubMed ID: 22124255
[TBL] [Abstract][Full Text] [Related]
18. Voluntary exercise induces structural remodeling in the hearts of dystrophin-deficient mice.
Costas JM; Nye DJ; Henley JB; Plochocki JH
Muscle Nerve; 2010 Dec; 42(6):881-5. PubMed ID: 21104863
[TBL] [Abstract][Full Text] [Related]
19. IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
Smith J; Goldsmith C; Ward A; LeDieu R
Cell Death Differ; 2000 Nov; 7(11):1109-18. PubMed ID: 11139285
[TBL] [Abstract][Full Text] [Related]
20. Voluntary physical activity protects from susceptibility to skeletal muscle contraction-induced injury but worsens heart function in mdx mice.
Hourdé C; Joanne P; Medja F; Mougenot N; Jacquet A; Mouisel E; Pannerec A; Hatem S; Butler-Browne G; Agbulut O; Ferry A
Am J Pathol; 2013 May; 182(5):1509-18. PubMed ID: 23465861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
